Divis Laboratories Ltd - Stock Price

  • NSE : DIVISLAB
  • BSE : 532488
  • ISIN CODE : INE361B01024
  • Industry : Pharmaceuticals & Drugs
  • House : Divis Labs
Divis Laboratories Ltd is not traded on BSE/NSE
NSE
1720.20
+1.6 %+27.1
BSE
1721.85
0 %0

Ratios

Parameter MAR 19  MAR 18  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)50.9633.0454.24
   CEPS(Rs)57.3238.4149.25
   DPS(Rs)16.0010.0060.00
   Book NAV/Share(Rs)262.09223.2017.42
   Tax Rate(%)27.0828.78-5.90
Margin Ratios
   Core EBITDA Margin(%)37.8732.2717.34
   EBIT Margin(%)37.6031.5319.25
   Pre Tax Margin(%)37.5031.4719.18
   PAT Margin (%)27.3522.4122.02
   Cash Profit Margin (%)30.7626.0618.07
Performance Ratios
   ROA(%)15.7811.1241.95
   ROE(%)21.0015.5535.09
   ROCE(%)28.5021.6831.46
   Asset Turnover(x)0.580.5016.33
   Sales/Fixed Asset(x)1.981.885.21
   Working Capital/Sales(x)1.301.0129.02
Efficiency Ratios
   Fixed Capital/Sales(x)0.510.53-4.95
   Receivable days80.3589.33-10.05
   Inventory Days115.23124.56-7.49
   Payable days52.2160.15-13.19
Valuation Parameters
   PER(x)33.4232.981.35
   PCE(x)29.7128.374.74
   Price/Book(x)6.504.8833.13
   Yield(%)0.940.922.35
   EV/Net Sales(x)9.147.4223.18
   EV/Core EBITDA(x)22.2820.986.21
   EV/EBIT(x)24.3123.403.86
   EV/CE(x)5.143.4648.58
   M Cap / Sales9.147.4322.99
Growth Ratio
   Net Sales Growth(%)27.10-4.25737.33
   Core EBITDA Growth(%)47.41-9.58594.79
   EBIT Growth(%)50.75-11.80530.17
   PAT Growth(%)54.24-17.30413.63
   EPS Growth(%)54.24-17.30413.63
Financial Stability Ratios
   Total Debt/Equity(x)0.020.0142.50
   Current Ratio(x)5.496.94-20.88
   Quick Ratio(x)3.404.87-30.27
   Interest Cover(x)397.38520.55-23.66
   Total Debt/Mcap(x)0.000.007.04

Latest News

close